Rate and document adverse events using standardized severity grades from 1 to 5. Search for AE terms and their definitions. Record event details and track changes over time. Share reports with healthcare providers.
Track history across multiple providers to inform care decisions. Receive personalized plans based on medical history. Access preventive assessments to identify risks and guide wellness actions. Coordinate care with integrated resources.
The app allows breast cancer survivors to visualize mastectomy tattoos on their bodies. Users can select a body type or upload a photo to preview designs and find experienced tattoo artists.
Track medication intake with step-by-step guidance and reminders. Complete questionnaires and log visits. Receive support for clinical trial participation. Sync health data with healthcare providers.
Clinicians use the to access evidence-based medical content for . They ask voice-enabled questions to navigate information. The provides clinical decision support tools to aid in diagnosis and treatment planning.
Uro-oncology education for healthcare professionals.
The app provides narrated simulation videos explaining uro-oncology pathologies and therapies. It enhances communication between healthcare professionals and patients, and aids students in learning urological and oncological topics.
The app offers offline access to adverse event terminology and performance status scales for healthcare professionals. It includes NCI CTC-AE, ECOG, Karnofsky, and Lansky scales, with user notes stored privately in iCloud and exportable as CSV.
Learn about various types including breast, bone, brain, colon, eye, kidney, lung, liver, skin, and others. Explore how starts in cells and covers abnormal growth processes. Access educational content on development and cellular changes.
Enter patient parameters from an echo assessment to determine probable severity and etiology of mitral regurgitation. Review customized advice on referral necessity and treatment options including mitral valve repair or replacement feasibility.